Become A Featured Company

How to Invest in Marijuana Stocks on Robinhood

Kelly Weimert

April 25th, 2017

News, Top News

Paying stock brokers hefty commissions on trades is a problem all stock traders eagerly aim to avoid, which is why the Robinhood app has become so popular among investors.

Essentially, Robinhood is a commission-free trading app that offers a vast range of different stock options that can be traded without enduring the costly fees of a stock broker. So, naturally, more and more people who are interested in investing in the cannabis industry are looking to the mobile app to see if they can reap the same commission-free benefits on marijuana investments. And in that regard, there’s good news and bad news.

Currently, Robinhood offers the opportunity to trade over 5,000 securities within the app, which includes most U.S. equities and exchange trade funds (ETFs) that are listed on major U.S. exchanges. But as of right now, the app doesn’t offer the ability to trade over-the-counter (OTC) stocks (e.g. non-NASDAQ and NYSE) or foreign stocks, which poses an obstacle for cannabis investors.

The majority of existing cannabis stocks are either traded via OTC markets or on foreign markets, including the TSX Ventures Exchange, the CSE, the Frankfurt Stock Exchange, the Tel Aviv Stock Exchange, and the Australian Securities Exchange. And that means, for now, major marijuana stocks can’t be traded on the app.

But all is not lost if you’re a cannabis investor seeking commission-free trading on Robinhood.

A handful of cannabis-related stocks are currently available on NASDAQ and NYSE

For starters, while the number of cannabis companies listed on the NASDAQ and NYSE is low, there are a few marijuana-related stocks that can be found there and traded commission-free on Robinhood, including:

  • 22nd Century Group Inc.
  • The Scotts Miracle-Gro Company
  • Innovative Industrial Properties, Inc.
  • Intec Pharma Ltd.
  • Compass Diversified Holdings
  • Cara Therapeutics Inc.
  • GW Pharmaceuticals Plc.
  • Insys Therapeutics Inc.
  • Therapix Biosciences Ltd.
  • Zynerba Pharmaceuticals Inc.

And because the cannabis industry is rapidly growing and evolving, this list is expected to grow much longer as smaller marijuana and marijuana-related companies join larger companies that are already listed on the NASDAQ and NYSE.

The impending launch of U.S.-based cannabis ETFs 

Additionally, with the expected launch of a variety of U.S.-based cannabis exchange-traded funds (ETFs) in the near future, it’s reasonable to assume that once these are available for general trading, investors will soon be able to trade them commission-free on Robinhood as well.

Robinhood hopes to expand future availability

Another point of hope comes from the developers of the Robinhood app who have expressed via their website the desire to support additional securities in the future, including:

  • Foreign domiciled securities
  • OTC equities
  • Options
  • Preferred stocks
  • Tracking stocks
  • Warrants
  • Mutual funds
  • Bonds and fixed income trading
  • Foreign exchange

So, while opportunities for cannabis investors on the app are currently limited, the potential for an expansion of access in the future is promising given the company’s expressed desire to do so.

Bottom line for Robinhood cannabis investors

The unprecedented nature of the cannabis industry makes its future uncertain across many avenues, and the Robinhood app is no exception. However, given the exponential increase in cannabis interest and sales, it’s safe to assume that current cannabis companies will continue to grow and ultimately join bigger NASDAQ and NYSE companies, making them available on the app. That fact, coupled with Robinhood’s aims to increase securities support, makes the future of cannabis trading within the app promising, so investors would be smart to keep their eye on it. And playing with the handful of NASDAQ cannabis stocks currently available in Robinhood is a great way to dip your toe in the commission-free trading waters in the meantime.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Kelly Weimert

Kelly is a full-time freelance writer based in Austin, TX. A happy hybrid of geek and hippie, when she's not nestled into her couch crankin' out crafty prose with her miscreant Chihuahua, you can find her frolicking outside to keep her sanity in check.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading